Souvenaid

Souvenaid is the name of a medical nutrition formulation, presented as a drink, that has been studied for potential use in the dietary management of early Alzheimer’s disease. Randomised controlled trials have shown that Souvenaid modestly improves memory in subjects with early Alzheimer’s disease while showing insignificant benefits in other tests of cognitive function. The purported benefits of Souvenaid have been criticised as "modest at best" and "of dubious clinical significance".

Souvenaid was developed by Advanced Medical Nutrition division of Nutricia and contains a patented combination of nutrients, referred to under the trademark Fortasyn Connect™. Souvenaid was designed to support synapse formation and function in early Alzheimer’s disease.